Wallace Hart LLC Has $674,000 Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Wallace Hart LLC lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 51.0% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 1,292 shares of the medical equipment provider's stock after selling 1,344 shares during the period. Intuitive Surgical accounts for 0.5% of Wallace Hart LLC's portfolio, making the stock its 9th largest position. Wallace Hart LLC's holdings in Intuitive Surgical were worth $674,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Massachusetts Financial Services Co. MA bought a new stake in shares of Intuitive Surgical in the third quarter worth about $558,807,000. Proficio Capital Partners LLC raised its holdings in Intuitive Surgical by 89,098.8% during the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock worth $495,845,000 after buying an additional 948,902 shares during the period. FMR LLC lifted its stake in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock valued at $5,389,765,000 after buying an additional 838,793 shares in the last quarter. Raymond James Financial Inc. bought a new stake in shares of Intuitive Surgical during the fourth quarter worth $313,769,000. Finally, Wilmington Savings Fund Society FSB increased its position in shares of Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock worth $272,980,000 after acquiring an additional 552,058 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Remove Ads

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 269 shares of the business's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the sale, the chief financial officer now directly owns 3,282 shares in the company, valued at $1,936,380. The trade was a 7.58 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 13,309 shares of company stock worth $7,611,004. Insiders own 0.90% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and upped their target price for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Tuesday, November 19th. Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. BTIG Research increased their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a report on Tuesday, November 26th. Finally, Raymond James lifted their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $613.10.

Intuitive Surgical Trading Up 1.2 %

Shares of NASDAQ:ISRG traded up $5.91 on Wednesday, hitting $499.63. The company had a trading volume of 1,677,837 shares, compared to its average volume of 1,421,899. The stock has a 50 day moving average price of $569.91 and a 200 day moving average price of $531.84. The stock has a market cap of $177.96 billion, a price-to-earnings ratio of 78.00, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.